[{"address1": "240 East Grand Avenue", "address2": "2nd Floor", "city": "South San Francisco", "state": "CA", "zip": "94080", "country": "United States", "phone": "650 388 5600", "website": "https://www.oricpharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies to counter the resistance mechanisms cancers in the United States. Its clinical stage product candidates include ORIC-114, a brain penetrant orally bioavailable irreversible inhibitor, currently under Phase 1b study, that selectively target epidermal growth factor receptor (EGFR) exon 20 and human epidermal growth factor receptor 2 exon 20 with high potency towards exon 20 insertion mutations; and ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 for prostate cancer, currently under Phase 1b study. The company develops ORIC-533, an orally bioavailable small molecule inhibitor of CD73; and ORIC-613, a small molecule therapeutic intended to address a mechanism of innate resistance found in a subset of breast cancers. It has clinical development collaboration agreement for a potential Phase 2 study of ORIC-533 in multiple myeloma with Pfizer Inc.; a clinical trial collaboration and supply agreement with Bayer to evaluate ORIC-944 in combination with Nubeqa AR inhibitor; and a clinical trial collaboration and supply agreement with Johnson & Johnson to evaluate ORIC 944 in combination with Erleada AR inhibitor. The company was incorporated in 2014 and is headquartered in South San Francisco, California.", "fullTimeEmployees": 128, "companyOfficers": [{"maxAge": 1, "name": "Dr. Richard A. Heyman Ph.D.", "age": 67, "title": "Founder, Independent Chairman & Member of Scientific Advisory Board", "yearBorn": 1957, "fiscalYear": 2024, "totalPay": 100000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jacob M. Chacko M.B.A., M.D.", "age": 45, "title": "President, CEO & Director", "yearBorn": 1979, "fiscalYear": 2024, "totalPay": 1039037, "exercisedValue": 0, "unexercisedValue": 8489789}, {"maxAge": 1, "name": "Mr. Dominic G. Piscitelli CPA, M.B.A.", "age": 49, "title": "Chief Financial Officer", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": 684155, "exercisedValue": 0, "unexercisedValue": 1460951}, {"maxAge": 1, "name": "Dr. Pratik S. Multani M.D., M.S.", "age": 57, "title": "Chief Medical Officer", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 735587, "exercisedValue": 0, "unexercisedValue": 2520060}, {"maxAge": 1, "name": "Dr. Charles L. Sawyers B.A., M.D., Ph.D.", "age": 65, "title": "Founder & Member of Scientific Advisory Board", "yearBorn": 1959, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Scott W. Lowe Ph.D.", "title": "Founder & Member of Scientific Advisory Board", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Kevin  Brodbeck Ph.D.", "title": "Chief Technical Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Lori Sickels Friedman Ph.D.", "age": 59, "title": "Chief Scientific Officer", "yearBorn": 1965, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Christian V. Kuhlen Esq., J.D., M.D.", "age": 51, "title": "General Counsel", "yearBorn": 1973, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel  Iazzetti", "title": "VP & Head of People", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 10, "boardRisk": 6, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1759276800, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 13.3, "open": 13.08, "dayLow": 12.62, "dayHigh": 13.35, "regularMarketPreviousClose": 13.3, "regularMarketOpen": 13.08, "regularMarketDayLow": 12.62, "regularMarketDayHigh": 13.35, "payoutRatio": 0.0, "beta": 1.676, "forwardPE": -6.2955666, "volume": 1086241, "regularMarketVolume": 1086241, "averageVolume": 1318300, "averageVolume10days": 1860950, "averageDailyVolume10Day": 1860950, "bid": 12.67, "ask": 12.84, "bidSize": 16, "askSize": 16, "marketCap": 1241231744, "fiftyTwoWeekLow": 3.895, "fiftyTwoWeekHigh": 14.93, "allTimeHigh": 40.81, "allTimeLow": 2.36, "fiftyDayAverage": 11.0965, "twoHundredDayAverage": 8.972325, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 966803776, "profitMargins": 0.0, "floatShares": 63511635, "sharesOutstanding": 97122987, "sharesShort": 11242529, "sharesShortPriorMonth": 8174386, "sharesShortPreviousMonthDate": 1756425600, "dateShortInterest": 1759190400, "sharesPercentSharesOut": 0.1158, "heldPercentInsiders": 0.06712, "heldPercentInstitutions": 0.99249, "shortRatio": 8.1, "shortPercentOfFloat": 0.1172, "impliedSharesOutstanding": 97122987, "bookValue": 3.759, "priceToBook": 3.3998404, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -137248992, "trailingEps": -1.89, "forwardEps": -2.03, "enterpriseToEbitda": -6.511, "52WeekChange": 0.4013158, "SandP52WeekChange": 0.13837254, "quoteType": "EQUITY", "currentPrice": 12.78, "targetHighPrice": 25.0, "targetLowPrice": 12.0, "targetMeanPrice": 18.0, "targetMedianPrice": 18.0, "recommendationMean": 1.16667, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 11, "totalCash": 282512992, "totalCashPerShare": 2.909, "ebitda": -148484000, "totalDebt": 8085000, "quickRatio": 15.652, "currentRatio": 16.129, "debtToEquity": 2.495, "returnOnAssets": -0.27685, "returnOnEquity": -0.43822, "freeCashflow": -72467752, "operatingCashflow": -120226000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "ORIC", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "messageBoardId": "finmb_303713108", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -3.90978, "regularMarketPrice": 12.78, "shortName": "Oric Pharmaceuticals, Inc.", "longName": "ORIC Pharmaceuticals, Inc.", "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1760742948, "regularMarketTime": 1760731200, "exchange": "NMS", "firstTradeDateMilliseconds": 1587735000000, "postMarketChangePercent": 1.95618, "postMarketPrice": 13.03, "postMarketChange": 0.25, "regularMarketChange": -0.52, "regularMarketDayRange": "12.62 - 13.35", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1318300, "fiftyTwoWeekLowChange": 8.885, "fiftyTwoWeekLowChangePercent": 2.2811298, "fiftyTwoWeekRange": "3.895 - 14.93", "fiftyTwoWeekHighChange": -2.1500006, "hasPrePostMarketData": true, "fiftyTwoWeekHighChangePercent": -0.14400539, "fiftyTwoWeekChangePercent": 40.13158, "earningsTimestampStart": 1762891200, "earningsTimestampEnd": 1762891200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.89, "epsForward": -2.03, "epsCurrentYear": -1.70621, "priceEpsCurrentYear": -7.4902854, "fiftyDayAverageChange": 1.6834993, "fiftyDayAverageChangePercent": 0.15171444, "twoHundredDayAverageChange": 3.8076744, "twoHundredDayAverageChangePercent": 0.4243799, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.2 - Strong Buy", "cryptoTradeable": false, "displayName": "ORIC Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-10-18"}]